Synthesis and N-Methyl-D-aspartate (NMDA) Receptor Activity of Ketamine Metabolites

被引：65

作者：

Morris, Patrick J. ^{[1
]}

Moaddel, Ruin ^{[2
]}

Zanos, Panos ^{[3
]}

Moore, Curtis E. ^{[4
]}

Gould, Todd ^{[3
,5
,6
]}

Zarate, Carlos A., Jr. ^{[7
]}

Thomas, Craig J. ^{[1
]}

机构：

[1] NIH, Div Preclin Innovat, Natl Ctr Adv Translat Sci, Rockville, MD 20850 USA

[2] NIA, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA

[3] Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA

[4] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA

[5] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA

[6] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA

[7] NIMH, Expt Therapeut & Pathophysiol Branch, NIH, Bethesda, MD 20892 USA

来源：

ORGANIC LETTERS | 2017年 / 19卷 / 17期

关键词：

ANTIDEPRESSANT; MECHANISMS; DEPRESSION; AMINATION; CURRENTS; PLASMA;

D O I：

10.1021/acs.orglett.7b02177

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Ketamine is rapidly metabolized in the human body to a variety of metabolites, including the hydroxynorketamines. At least two hydroxynorketamines have significant antidepressant action in rodent models, with limited action against the N-methyl-D-aspartate (NMDA) receptor. The synthesis of 12 hydroxynorketamines and their binding affinity to the NMDA receptor is presented here.

引用

页码：4572 / 4575

页数：4

共 50 条

[31] The N-methyl-D-aspartate receptor and schizophrenia
Strous, RD
Javitt, DC
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1996, 32 (05): : 275 - 281
[32] AUTORADIOGRAPHIC ASSESSMENT OF THE EFFECTS OF N-METHYL-D-ASPARTATE (NMDA) RECEPTOR ANTAGONISTS INVIVO
MCCULLOCH, J
IVERSEN, LL
NEUROCHEMICAL RESEARCH, 1991, 16 (09) : 951 - 963
[33] BLOCKADE OF SODIUM CURRENTS BY MODULATORS OF N-METHYL-D-ASPARTATE (NMDA) RECEPTOR CHANNEL
CONDER, ML
MCCULLOUGH, JR
BIOPHYSICAL JOURNAL, 1988, 53 (02) : A539 - A539
[34] N-methyl-D-aspartate (NMDA) receptor expression and function is required for early chondrogenesis
Matta, Csaba
Juhasz, Tam
Fodor, Janos
Hajdu, Tibor
Katona, Eva
Szucs-Somogyi, Csilla
Takacs, Roland
Vago, Judit
Olah, Tamas
Bartok, Adam
Varga, Zoltan
Panyi, Gyorgy
Csernoch, Laszlo
Zakany, Roza
CELL COMMUNICATION AND SIGNALING, 2019, 17 (01)
[35] Antidepressant effect of ketamine, a N-methyl-D-aspartate (NMDA) glutamate receptor antagonist, in the therapy of treatment-resistant depression
Gosek, Pawel
Chojnacka, Magdalena
Bienkowski, Przemyslaw
Swiecicki, Lukasz
PSYCHIATRIA POLSKA, 2012, 46 (02) : 283 - 294
[36] Direct inhibition of N-methyl-D-aspartate (NMDA)-receptor function by antiglaucomatous β-antagonists
Nagata, Tatsuo
Ueno, Susumu
Morita, Hirofumi
Kubota, Toshiaki
Toyohira, Yumiko
Tsutsui, Masato
Tawara, Akihiko
Yanagihara, Nobuyuki
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 (03) : 423 - 434
[37] EFFECTS OF THE NON-COMPETITIVE NMDA (N-METHYL-D-ASPARTATE) RECEPTOR ANTAGONIST KETAMINE ON SPATIAL-LEARNING IN THE RAT
ALESSANDRI, B
WELZL, H
BATTIG, K
PSYCHOPHARMACOLOGY, 1988, 96 (01) : S3 - S3
[38] N-methyl-D-aspartate (NMDA) receptor expression and function is required for early chondrogenesis
Csaba Matta
Tamás Juhász
János Fodor
Tibor Hajdú
Éva Katona
Csilla Szűcs-Somogyi
Roland Takács
Judit Vágó
Tamás Oláh
Ádám Bartók
Zoltan Varga
Gyorgy Panyi
László Csernoch
Róza Zákány
Cell Communication and Signaling, 17
[39] N-methyl-d-aspartate (NMDA) receptor antibodies encephalitis mimicking an autistic regression
Hacohen, Yael
Wright, Sukhvir
Gadian, Jonathan
Vincent, Angela
Lim, Ming
Wassmer, Evangeline
Lin, Jean-Pierre
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2016, 58 (10): : 1092 - 1094
[40] Pediatric N-Methyl-d-Aspartate (NMDA) Receptor Encephalitis, With and Without Herpes Encephalitis
Marcus, Lydia
Ness, Jayne M.
JOURNAL OF CHILD NEUROLOGY, 2021, 36 (09) : 743 - 751

← 1 2 3 4 5 →